PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2014

Akt-mTOR Pathway Inhibits Apoptosis and Fibrosis in Doxorubicin-Induced Cardiotoxicity Following Embryonic Stem Cell Transplantation.

Mouse / Chemical/toxin

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 24594448 ↗2014Reported benefit

Akt-mTOR Pathway Inhibits Apoptosis and Fibrosis in Doxorubicin-Induced Cardiotoxicity Following Embryonic Stem Cell Transplantation.

MouseChemical/toxinC57BL/6Transplantation into the heartAfter induction of doxorubicin cardiomyopathy, with assessment 4 weeks later

Model: Chronic doxorubicin-induced cardiomyopathy

Four weeks after injury, embryonic stem cell and conditioned medium treated hearts showed significantly fewer apoptotic nuclei, reduced cytoplasmic vacuolisation, less fibrosis with downregulated MMP-9 activity, diminished oxidative stress and preserved antioxidant defences, with modulation of PTEN…

Extraction: extract · Supplied extraction confidence: 0.55. Machine-extracted fields require source verification.